Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
694.4 INR | -0.69% | -0.81% | -13.12% |
May. 01 | Rossari Biotech's Consolidated Profit Climbs in FIscal Q4 | MT |
Apr. 30 | Transcript : Rossari Biotech Limited, Q4 2024 Earnings Call, Apr 30, 2024 |
Sales 2024 | 18.31B 220M | Sales 2025 * | 20.91B 251M | Capitalization | 38.41B 461M |
---|---|---|---|---|---|
Net income 2024 | 1.31B 15.7M | Net income 2025 * | 1.64B 19.76M | EV / Sales 2024 | 2.04 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.84 x |
P/E ratio 2024 |
28.7
x | P/E ratio 2025 * |
23.3
x | Employees | 500 |
Yield 2024 * |
0.44% | Yield 2025 * |
0.37% | Free-Float | 31.68% |
Latest transcript on Rossari Biotech Limited
1 day | -0.61% | ||
1 week | -0.71% | ||
Current month | -7.25% | ||
1 month | -7.84% | ||
3 months | -9.39% | ||
6 months | -2.67% | ||
Current year | -13.04% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 58 | 96-12-31 | |
Edward Menezes
FOU | Founder | 63 | 96-12-31 |
Ketan Sablok
DFI | Director of Finance/CFO | - | 23-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 50 | 23-04-28 | |
Edward Menezes
FOU | Founder | 63 | 96-12-31 |
Founder | 58 | 96-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 694.4 | -0.69% | 41 137 |
24-05-18 | 695.2 | -0.56% | 14,551 |
24-05-17 | 699.2 | -0.30% | 41,156 |
24-05-16 | 701.3 | -0.04% | 29,594 |
24-05-15 | 701.6 | +0.24% | 51,830 |
Delayed Quote NSE India S.E., May 21, 2024 at 04:04 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.04% | 461M | |
+3.80% | 49.69B | |
+20.29% | 42.41B | |
+23.39% | 26.65B | |
+12.85% | 19.62B | |
+0.75% | 17.1B | |
-24.51% | 15.43B | |
+3.72% | 15.64B | |
-9.92% | 15.3B | |
-18.80% | 13.97B |
- Stock Market
- Equities
- ROSSARI Stock